Singapore markets closed
Straits Times Index
3,292.69 +10.64 (+0.32%) Nikkei
38,274.05 -131.61 (-0.34%) Hang Seng
17,763.03 +16.12 (+0.09%) FTSE 100
8,144.13 -2.90 (-0.04%) Bitcoin USD
59,635.47 -3,769.68 (-5.95%) CMC Crypto 200
1,278.69 -60.38 (-4.51%)
Wilmar International Limited (F34.SI)
SES - SES Delayed price. Currency in SGD
Add to watchlist
At close: 05:13PM SGT
| Previous close | 3.3400 |
| Open | 3.2800 |
| Bid | 3.2200 x 0 |
| Ask | 3.2400 x 0 |
| Day's range | 3.1700 - 3.2800 |
| 52-week range | 3.0700 - 4.1000 |
| Volume | |
| Avg. volume | 5,506,369 |
| Market cap | 20.164B |
| Beta (5Y monthly) | 0.51 |
| PE ratio (TTM) | 9.79 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.17 (5.26%) |
| Ex-dividend date | 29 Apr 2024 |
| 1y target est | N/A |
- PR Newswire
Cerecin forges strategic partnership with A*STAR's Institute of Molecular and Cell Biology (IMCB) in Singapore to advance R&D in neurological disorders.
Cerecin Inc., a clinical-stage biotechnology company at the forefront of developing innovative neurotherapeutics, is pleased to announce the establishment of a Memorandum of Understanding (MOU) with A*STAR's Institute of Molecular and Cell Biology (IMCB). This collaboration aims to accelerate research and treatment initiatives for neurological disorders and diseases to enhance overall health and brain function.
© 2024 Yahoo. All rights reserved.